NCT04565288View on ClinicalTrials.gov

Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

May 16, 2023

Study Completion Date

May 16, 2023

Conditions
Alcohol Use Disorder
Interventions
DRUG

Atomoxetine

Participants randomized to receive the study medication, atomoxetine (brand name: Straterra) for 6-weeks (40 mg/day for 3 days then 80 mg/day thereafter). A comparator group will receive placebo (sugar pills).

DRUG

Placebo

Matching placebo (sugar pill)

Trial Locations (1)

02903

Brown University Center for Alcohol and Addiction Studies, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Brown University

OTHER